RTI Biologics Inc. makes use of natural tissues and technologies to produce orthopedic, cardiovascular and other surgical implants that repair and promote the natural healing of human bone and other human tissues, and improve surgical outcomes. The Company processes human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine animal tissue in producing allografts. The Company processes human and bovine animal tissue and distributes the tissue through various distribution channels. The Company processes two facilities in Alachua, Florida and one facility in Germany and distributes its products and services in all 50 states and in over 31 countries worldwide. The Company separates its products into six primary product lines: spine, sports medicine, dental, surgical specialties, bone graft substitutes and general orthopedic.